Fibroblast Growth Factor 14 (FGF14) is a member of the fibroblast growth factor family, which is known for its broad mitogenic and cell survival activities. These growth factors are involved in various biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. FGF14, in particular, plays a crucial role in the central nervous system.
FGF14 is a protein that is encoded by the FGF14 gene in humans. It is part of the intracellular FGF subfamily, which also includes FGF11, FGF12, and FGF13. Unlike other FGFs that function as secreted signaling molecules, FGF14 operates within cells. It interacts with voltage-gated sodium channels and is essential for the proper functioning of neurons.
The primary structure of FGF14 consists of a single polypeptide chain. The recombinant form of FGF14 is produced using recombinant DNA technology, where the FGF14 gene is inserted into a suitable expression system, such as E. coli or mammalian cells, to produce the protein in large quantities.
FGF14 is predominantly expressed in the brain and spinal cord. It is involved in the regulation of neuronal excitability and synaptic transmission. FGF14 binds to the intracellular C-terminal domain of voltage-gated sodium channels, influencing their activity and, consequently, the electrical signaling in neurons.
Mutations in the FGF14 gene have been linked to neurological disorders, such as spinocerebellar ataxia type 27 (SCA27), which is characterized by progressive problems with movement and coordination. This highlights the importance of FGF14 in maintaining normal neurological function.
Recombinant FGF14 is used extensively in research to study its role in neuronal function and its potential implications in neurological diseases. By understanding how FGF14 interacts with sodium channels and other cellular components, researchers can develop targeted therapies for conditions like SCA27 and other neurodegenerative diseases.
In addition, FGF14 has potential therapeutic applications. For instance, modulating FGF14 activity could be a strategy to treat certain neurological disorders. However, more research is needed to fully understand its therapeutic potential and to develop safe and effective treatments.